At this moment I can imagine at least a few face palms after reading a headline like that. But Meghan Fitzgerald, Corporate Strategy EVP with Cardinal Health, said it is a sensible option for risk averse companies that still want to benefit from innovative approaches to healthcare, and it’s a trend we should expect to see more of this year.
Fitzgerald made the comments as part of a fireside chat at the StartUp Health Festival with Matthew McAskin, Evercore Partners Senior Managing Director, against the backdrop of the J.P. Morgan Healthcare Conference.
“Buying a company used to always be the solution, but buying a minority stake can be a [viable option]. Having a few partners means you don’t have to go it alone,” Fitzgerald said. One partner Fitzgerald referenced was CVS Health.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Update In a tweet later in the day, Fitzgerald clarified that she did not mean to suggest that M&A is stopping or even slowing down.
https://twitter.com/MMAMeg/status/687065589001498624
It’s an interesting point from a company that has made so many acquisitions become the healthcare behemoth it is. Just last year it acquired naviHealth after buying a 71 percent stake in the business. But that deal also reflected a growing trend for the company of adding healthcare services.
In a year when consolidation in healthcare is widely anticipated, it will be interesting to see whether Fitzgerald’s assertion holds.